NVCR - Novocure Ltd (NVCR) CEO Asaf Danziger on Q3 2020 Results - Earnings Call Transcript

Novocure Ltd (NVCR) Q3 2020 Earnings Conference Call October 29, 2020, 08:00 ET Company Participants Gabrielle Fernandes - Director, IR William Doyle - Executive Chairman Asaf Danziger - President, CEO & Director Ashley Cordova - CFO & VP, IR Ely Benaim - Chief Medical Officer Uri Weinberg - Chief Science Officer Pritesh Shah - Chief Commercial Officer Conference Call Participants Jason Bednar - Piper Sandler & Co. Lawrence Biegelsen - Wells Fargo Securities Vijay Kumar - Evercore ISI Gregory Gilbert - Truist Securities Jason Wittes - Northland Capital Markets Difei Yang - Mizuho Securities Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure Third Quarter Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Gabrielle Fernandes, Director of Investor Relations. Please go ahead, ma'am. Gabrielle Fernandes Good morning, everyone, and thank you for joining us

For further details see:

Novocure Ltd (NVCR) CEO Asaf Danziger on Q3 2020 Results - Earnings Call Transcript